BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21542274)

  • 1. [Plasma cell separation algorithm from bone marrow samples].
    Buresová I; Kyjovská D; Kovárová L; Moravcová J; Suská R; Perutka T; Cumová J; Hájek R
    Klin Onkol; 2011; 24(1):35-40. PubMed ID: 21542274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimizing plasma cell content in bone marrow aspirates].
    Hoffmann T; Favre G; Gratwohl A; Passweg J; Mathys S; Borel J; Speck B; Tichelli A
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1611-3. PubMed ID: 9824893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
    Orfäo A; García-Sanz R; López-Berges MC; Belén Vidriales M; González M; Caballero MD; San Miguel JF
    Cytometry; 1994 Dec; 17(4):332-9. PubMed ID: 7533074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 6. Sample processing and methodological pitfalls in multiple myeloma research.
    Potácová A; Stossová J; Buresová I; Kovárová L; Almási M; Penka M; Hájek R
    Klin Onkol; 2011; 24 Suppl():S18-23. PubMed ID: 21923059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature.
    Matoso A; Rizack T; Treaba DO
    Diagn Pathol; 2010 Jan; 5():6. PubMed ID: 20205792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
    Nadav L; Katz BZ; Baron S; Yossipov L; Polliack A; Deutsch V; Geiger B; Naparstek E
    Br J Haematol; 2006 Jun; 133(5):530-2. PubMed ID: 16681641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
    Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
    Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using aspirates for multiple myeloma research probably excludes important data.
    Ely S
    Br J Haematol; 2006 Jul; 134(2):245-6. PubMed ID: 16846488
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
    Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
    J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phagocytic plasma cells in a patient with multiple myeloma].
    Monsalve CR; Martín CA
    Sangre (Barc); 1991 Feb; 36(1):73-4. PubMed ID: 1853277
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nuclear lobulation in the plasma cells of a patient with multiple myeloma (Bence Jones type)].
    Fujii H; Maekawa T; Nishida K; Urata Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2086-90. PubMed ID: 3236416
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma discrimination by computerized triple matrix analysis of list mode data from three-color flow cytometric immunophenotypes of bone marrow aspirates.
    Bartsch R; Arland M; Lange S; Kahl C; Valet G; Höffkes HG
    Cytometry; 2000 Sep; 41(1):9-18. PubMed ID: 10942891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
    Galani Z; Viniou N; Kyrtsonis MC; Sachanas S; Antoniou T; Dimopoulou MN; Vassilakopoulos TP; Korkolopoulou P; Nakopoulou L; Patsouris E; Pangalis GA
    Anticancer Res; 2007; 27(1B):571-4. PubMed ID: 17348443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.